# China NMPA Drug Inspection - Shanghai Huangxiang Tieli Lantian Pharmaceutical Co., Ltd. - Berberine Hydrochloride Tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/shanghai-huangxiang-tieli-lantian-pharmaceutical-co-ltd/d70098b7-e804-4d06-96ee-61e62a3d3032/
Source feed: China

> China NMPA drug inspection for Shanghai Huangxiang Tieli Lantian Pharmaceutical Co., Ltd. published March 25, 2020. Drug: Berberine Hydrochloride Tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Drug Quality Bulletin of Guangxi Zhuang Autonomous Region Drug Administration (Issue 1, 2020)
- Company Name: Shanghai Huangxiang Tieli Lantian Pharmaceutical Co., Ltd.
- Publication Date: 2020-03-25
- Drug Name: Berberine Hydrochloride Tablets
- Inspection Finding: [Characteristics]
- Action Taken: The Guangxi Zhuang Autonomous Region Drug Administration has organized relevant drug supervision and management departments to take necessary control measures against drugs that do not meet the standards and to handle them in accordance with the law.

Company: https://www.globalkeysolutions.net/companies/shanghai-huangxiang-tieli-lantian-pharmaceutical-co-ltd/394bf645-a2d9-4296-91c7-a19583547e38/
